| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 333,476 | 328,749 | 325,749 | 366,573 | | Cost of Revenue | 291,980 | 290,361 | 289,759 | 328,582 | | | Gross Profit | 41,496 | 38,388 | 35,990 | 37,991 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 32,402 | 31,606 | 30,327 | 31,622 | | Non Recurring |
-
|
-
|
-
| 93,882 | | Others | 2,433 | 1,597 | 1,380 | 2,366 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,661 | 5,185 | 4,283 | (89,879) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,661 | 5,185 | 4,283 | (89,879) | | Interest Expense | 447 | 430 | 594 | 780 | | Income Before Tax | 6,214 | 4,755 | 3,689 | (90,659) | | Income Tax Expense | 467 | 378 | 404 | (14,075) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,747 | 4,377 | 3,285 | (76,584) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,747 | 4,377 | 3,285 | (76,584) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,747 | $4,377 | $3,285 | ($76,584) |
|
0.50% Nasdaq 
Income Statement
